{"text": ["Eli", "Lilly's", "Mirikizumab", "Beat", "Placebo", "At", "Controlling,", "Resolving", "Ulcerative", "Colitis", "Symptoms"], "created_at": "2021-03-16 16:27:44"}
{"text": ["Lilly", "(LLY)", "Down", "as", "Alzheimer's", "Drug", "Fails", "Investor", "Expectation"], "created_at": "2021-03-16 15:20:03"}
{"text": ["Dip", "in", "Eli", "Lilly", "Stock", "Makes", "It", "a", "Buy,", "Mizuho", "Analyst", "Says"], "created_at": "2021-03-16 13:30:00"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "MGM", "Resorts,", "American", "Airlines,", "Blackstone", "Group,", "Extended", "Stay", "America", "and", "Eli", "Lilly"], "created_at": "2021-03-16 12:38:12"}
{"text": ["AstraZeneca", "to", "supply", "U.S.", "with", "extra", "500,000", "doses", "of", "COVID-19", "antibody-based", "cocktail"], "created_at": "2021-03-16 11:35:00"}
{"text": ["UPDATE", "1-Eli", "Lilly", "bowel", "disease", "treatment", "succeeds", "in", "late-stage", "study"], "created_at": "2021-03-16 11:06:44"}
{"text": ["Lilly's", "Mirikizumab", "Helps", "Patients", "Achieve", "Clinical", "Remission", "and", "Improves", "Symptoms", "in", "Adults", "with", "Ulcerative", "Colitis", "in", "12-Week", "Phase", "3", "Induction", "Study"], "created_at": "2021-03-16 10:45:00"}
